Flputnam Investment Management Co. Sells 6,669 Shares of Agilent Technologies, Inc. $A

Flputnam Investment Management Co. lessened its position in shares of Agilent Technologies, Inc. (NYSE:A) by 11.8% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 49,960 shares of the medical research company’s stock after selling 6,669 shares during the period. Flputnam Investment Management Co.’s holdings in Agilent Technologies were worth $6,798,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Bridgefront Capital LLC bought a new position in Agilent Technologies during the third quarter worth $1,323,000. Wellington Management Group LLP raised its stake in Agilent Technologies by 4.8% during the third quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock worth $1,203,990,000 after buying an additional 433,342 shares during the last quarter. Envestnet Asset Management Inc. raised its stake in Agilent Technologies by 3.8% during the third quarter. Envestnet Asset Management Inc. now owns 607,914 shares of the medical research company’s stock worth $78,026,000 after buying an additional 22,498 shares during the last quarter. Generation Investment Management LLP raised its stake in Agilent Technologies by 10.1% during the third quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock worth $816,043,000 after buying an additional 582,093 shares during the last quarter. Finally, Champlain Investment Partners LLC raised its stake in Agilent Technologies by 33.3% during the third quarter. Champlain Investment Partners LLC now owns 895,770 shares of the medical research company’s stock worth $114,972,000 after buying an additional 223,750 shares during the last quarter.

Agilent Technologies Trading Up 0.6%

A opened at $115.82 on Thursday. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $160.27. The company has a current ratio of 2.07, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44. The company has a market cap of $32.73 billion, a P/E ratio of 25.57, a price-to-earnings-growth ratio of 2.42 and a beta of 1.22. The company has a fifty day moving average price of $114.99 and a two-hundred day moving average price of $128.79.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The firm had revenue of $1.84 billion during the quarter, compared to the consensus estimate of $1.80 billion. During the same period in the previous year, the firm posted $1.31 earnings per share. The business’s revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Analysts predict that Agilent Technologies, Inc. will post 5.95 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.255 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.9%. Agilent Technologies’s payout ratio is presently 22.52%.

Key Headlines Impacting Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent beat Q2 fiscal 2026 estimates, posting adjusted EPS of $1.49 versus the $1.40 consensus and revenue of $1.83 billion versus $1.80 billion expected, with revenue up 10% year over year. Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: The company raised its FY 2026 profit forecast, signaling confidence in demand for lab tools and equipment used in research and diagnostics. Agilent raises 2026 profit forecast on strong demand for lab tools
• Positive Sentiment: Agilent’s FY 2026 guidance came in slightly above consensus, while its Q3 revenue outlook matched expectations and EPS guidance was near the top of the range, reinforcing stable near-term execution. Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: Analysts turned more constructive, with RBC initiating/covering the stock at outperform and Baird lifting its price target, suggesting more upside if the company keeps delivering. Benzinga analyst update
• Neutral Sentiment: Agilent’s latest results also showed GAAP EPS of $1.20 and highlighted solid profitability metrics, but these were secondary to the stronger non-GAAP performance and guidance update.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Royal Bank Of Canada assumed coverage on shares of Agilent Technologies in a research note on Wednesday. They set an “outperform” rating and a $153.00 target price for the company. Morgan Stanley decreased their price target on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. Wall Street Zen downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Robert W. Baird lifted their price target on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research note on Tuesday. Finally, Wells Fargo & Company decreased their price target on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a research note on Thursday, February 26th. Two analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $162.40.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.